Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV003335559 | SCV004043236 | pathogenic | Juvenile polyposis syndrome | 2023-05-26 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |
Ambry Genetics | RCV004604939 | SCV005095274 | pathogenic | Hereditary cancer-predisposing syndrome | 2024-06-06 | criteria provided, single submitter | clinical testing | The p.Y176* pathogenic mutation (also known as c.528C>A), located in coding exon 5 of the BMPR1A gene, results from a C to A substitution at nucleotide position 528. This changes the amino acid from a tyrosine to a stop codon within coding exon 5. This variant was reported in an individual with features consistent with juvenile polyposis syndrome (Ngeow J et al. Gastroenterology, 2013 Jun;144:1402-9, 1409.e1-5). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Fulgent Genetics, |
RCV005047537 | SCV005678933 | likely pathogenic | Polyposis syndrome, hereditary mixed, 2; Juvenile polyposis syndrome | 2024-05-21 | criteria provided, single submitter | clinical testing |